Loading…
MediWound Ltd. is projected to rise to $15.58 by 2027, a +10% move from its current price of $14.12. MDWD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $13.90 | $14.12 | $14.34 | -0.02% |
| Aug 5 | $13.81 | $14.11 | $14.42 | -0.05% |
| Aug 6 | $13.74 | $14.11 | $14.49 | -0.07% |
| Aug 7 | $13.68 | $14.11 | $14.55 | -0.10% |
| Aug 8 | $13.62 | $14.10 | $14.60 | -0.12% |
| Aug 9 | $13.58 | $14.10 | $14.64 | -0.15% |
| Aug 10 | $13.53 | $14.10 | $14.68 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.53 | $14.10 | $14.68 | -0.17% |
| Week 2 | $13.28 | $14.07 | $14.91 | -0.34% |
| Week 3 | $13.09 | $14.05 | $15.08 | -0.51% |
| Week 4 | $12.92 | $14.02 | $15.22 | -0.68% |
| Week 5 | $12.78 | $14.00 | $15.34 | -0.85% |
| Week 6 | $12.65 | $13.98 | $15.45 | -1.02% |
| Week 7 | $12.52 | $13.95 | $15.54 | -1.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MediWound Ltd. is a biopharmaceutical company that develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
MediWound Ltd. (MDWD) is a healthcare company with a current price of $14.62 and a market cap of $187.9M, ranking 3673. The asset trades in the small-cap space and operates within the healthcare sector focused on tissue repair and regenerative therapies.
A major floor 6.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 7.6% above — a clean break opens room to run.
A major ceiling 26.4% above — clearing it would confirm fresh momentum.
Key MDWD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MDWD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.33 | Sell | $14.25 | Sell |
| MA 10 | $14.34 | Sell | $14.32 | Sell |
| MA 20 | $14.43 | Sell | $14.41 | Sell |
| MA 50 | $14.56 | Sell | $14.80 | Sell |
| MA 100 | $15.69 | Sell | $15.50 | Sell |
| MA 200 | $16.87 | Sell | $16.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.01 | Neutral |
| Stoch RSI (14) | 5.41 | Buy |
| CCI (20) | -103.61 | Sell |
| Williams %R (14) | -96.15 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -0.42 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 3.85 | Buy |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 41.64 | Neutral |
| Momentum (10) | -0.49 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 14.24 | Sell |
| ADX (14) | 9.93 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 is 50, with a SMA50 of $14.78 and a SMA200 of $16.96. There is support at $13.87 and resistance at $15.19, and the thirty-day range runs from $13.09 to $16.33.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.73 | $14.12 | $16.98 | 0% | Neutral | |
| $12.78 | $15.58 | $19.85 | +10% | Neutral | |
| $13.30 | $16.53 | $21.65 | +17% | Neutral | |
| $12.97 | $16.37 | $21.89 | +16% | Neutral | |
| $14.35 | $18.35 | $24.99 | +30% | Bullish | |
| $16.81 | $21.76 | $30.11 | +54% | Bullish | |
| $18.80 | $24.63 | $34.56 | +74% | Bullish | |
| $19.59 | $25.92 | $36.85 | +84% | Bullish | |
| $19.78 | $26.44 | $38.04 | +87% | Bullish | |
| $20.84 | $28.12 | $40.90 | +99% | Bullish | |
| $30.25 | $42.57 | $64.91 | +202% | Bullish | |
| $51.72 | $78.08 | $127.63 | +453% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $13.73 | $14.12 | $16.59 | +0.00% |
| September 2026 | $11.65 | $13.65 | $16.37 | -3.32% |
| October 2026 | $11.72 | $13.81 | $16.68 | +1.15% |
| November 2026 | $11.87 | $14.04 | $17.06 | +1.64% |
| December 2026 | $11.72 | $13.90 | $16.98 | -0.96% |
Click any year to see its month-by-month MDWD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MDWD to range from $13.73 to $16.98 through 2026. The $14.12 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MDWD price prediction for 2027 points to an average of $15.58 (low $12.78, high $19.85) — a potential gain of +10% on today's $14.12. Price action looks broadly range-bound.
In 2028, MDWD is projected to trade between $13.30 and $21.65, averaging $16.53 — a potential gain of +17% from today's $14.12. That is up +6% on the projected 2027 average. A consolidation phase looks the most probable path here.
MediWound Ltd.'s 2029 outlook centres on $16.37, within a $12.97 to $21.89 range. That is -1% versus the projected 2028 average. That marks a +16% change versus current levels. Price action looks broadly range-bound.
By 2030, MDWD could reach as high as $24.99, with a base case around $18.35 and support toward $14.35 — roughly +30% from $14.12. Buyers look set to stay in control over this stretch.
Expect MDWD to range from $16.81 to $30.11 through 2031. The $21.76 average target implies a +54% move from current prices. That is up +19% on the projected 2030 average. Momentum favours further upside here.
The MDWD price prediction for 2032 points to an average of $24.63 (low $18.80, high $34.56) — a potential gain of +74% on today's $14.12. Buyers look set to stay in control over this stretch.
In 2033, MDWD is projected to trade between $19.59 and $36.85, averaging $25.92 — a potential gain of +84% from today's $14.12. That is up +5% on the projected 2032 average. Momentum favours further upside here.
MediWound Ltd.'s 2034 outlook centres on $26.44, within a $19.78 to $38.04 range. That is up +2% on the projected 2033 average. That marks a +87% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MDWD could reach as high as $40.90, with a base case around $28.12 and support toward $20.84 — roughly +99% from $14.12. Momentum favours further upside here.
Expect MDWD to range from $30.25 to $64.91 through 2040. The $42.57 average target implies a +202% move from current prices. That is up +51% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MDWD price prediction for 2050 points to an average of $78.08 (low $51.72, high $127.63) — a potential gain of +453% on today's $14.12. Momentum favours further upside here.
Investing $1,000 in MDWD today (≈ 70.82153 MDWD) could be worth
$5,529.98
+$4,529.98 (+453%) by 2050 · US Dollar
Based on the average projected MDWD price of $78.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDWDwould be worth at today's price.
$1,000 invested in MDWD on Jul 31, 2025 (≈ 53.64807 MDWD) would be worth
$757.51
-$242.49 (-24.2%) today · 0.76× · US Dollar
Based on a MDWD entry price of $18.64 vs. today's $14.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.23 | $992.27 | -0.8% |
| 1 month ago | $14.82 | $952.77 | -4.7% |
| 3 months ago | $16.63 | $849.07 | -15.1% |
| 6 months ago | $18.1 | $780.11 | -22.0% |
| 1 year ago | $18.64 | $757.51 | -24.2% |
| All time (5.0y) ago | $25.62 | $551.13 | -44.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MDWD forecast.
Our base-case forecast reaches $28.00 around 2035.
Implied market cap at $28.00: $359.86M
The multi-year forecast shows a rising path in the avg values and bullish sentiment beginning in 2030. For 2030, the avg is $19.16 with a min of $14.97 and a max of $26.09, and the forecast reflects a ROI of 31 with a BULLISH sentiment. The path continues to 2040, where the avg is $44.20, the min is $31.40, the max is $67.40, and ROI is 202.4 with a BULLISH sentiment.
By 2050, the avg is $81.37, the min is $53.89, the max is $133.01, and ROI is 456.6 with a BULLISH sentiment. These figures indicate a strong upward trajectory in the later years, though they are estimates and not guaranteed.
Tap a question to reveal the answer.
2030 avg $19.16 with min $14.97 and max $26.09; ROI 31; sentiment BULLISH.
The forecast shows bullish sentiment from 2030 onward with rising averages (e.g., 2030 avg $19.16; 2040 avg $44.20; 2050 avg $81.37), but these are estimates and not guaranteed.
Projected maxes include $26.09 in 2030, $67.40 in 2040, and $133.01 in 2050, suggesting $60 could be exceeded in 2040 or 2050 within the listed projections.
Current price $14.62 and market cap $187.9M.
The 30-day range is $13.09–$16.33 with RSI 50, SMA50 $14.78, SMA200 $16.96, support at $13.87, resistance at $15.19, and annualized volatility of 30%.
MediWound Ltd. Community Discussion
0Share your MediWound Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.